Physician profile
Roniel Cabrera
NPI 1619901717
$13,398.94
in general payments reported to CMS, 2019-2025
11 companies · $245 in 2025
The $245 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,316 · 2021: $4,560 · 2022: $43.29 · 2023: $125 · 2024: $110 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $402 · Education: $77.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $402.38 |
| Education | $77.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $6,530.38 | 2019-2023 | |
| Exelixis INC. | $6,422.89 | 2019-2021 | |
| Madrigal Pharmaceuticals | $143.14 | 2025 | Rezdiffra |
| Astrazeneca Pharmaceuticals LP | $109.56 | 2024 | |
| Ipsen Biopharmaceuticals, INC | $101.56 | 2025 | Bylvay |
| Mauna Kea Technologies, INC. | $48.12 | 2023 | |
| Fujifilm Healthcare Americas Corporation | $43.29 | 2022 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roniel Cabrera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.